---
title: "Blue Water Acquisition IV | 10-Q: FY2026 Q1 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286610281.md"
datetime: "2026-05-15T20:26:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286610281.md)
  - [en](https://longbridge.com/en/news/286610281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286610281.md)
---

# Blue Water Acquisition IV | 10-Q: FY2026 Q1 Revenue: USD 0

Revenue: As of FY2026 Q1, the actual value is USD 0.

EBIT: As of FY2026 Q1, the actual value is USD -363.87 K.

Blue Water Acquisition Corp. IV is a blank check company with no operating revenues to date, established on August 1, 2025, focusing on a business combination in the biotechnology, healthcare, and technology industries .

#### Operational Metrics (for the three months ended March 31, 2026)

-   Total Operating Expenses: $263,224, comprising $235,970 in formation, general and administrative expenses, $21,249 in legal and accounting expenses, $3,871 in administrative services fees to a related party, and $2,134 in insurance expense .
-   Loss from Operations: - $263,224 .
-   Other Income: $151,642, including $100,642 earned on cash and marketable securities held in the Trust Account and a $51,000 change in the fair value of the over-allotment option liability .
-   Net Loss: - $111,582 .

#### Cash Flow Highlights (for the three months ended March 31, 2026)

-   Net Cash Used in Operating Activities: - $1,289,937 .
-   Net Cash Used in Investing Activities: - $130,000,000, primarily due to investment in the Trust Account .
-   Net Cash Provided by Financing Activities: $131,289,937, mainly from proceeds from the issuance of Units and private placement units, offset by underwriting fees and promissory note payments .
-   Net Change in Cash: $0, with cash at the end of the period also being $0 .

#### Key Financial Position Metrics

-   Shareholders’ Deficit: - $3,683,626 as of March 31, 2026, compared to - $56,235 as of December 31, 2025 .
-   Working Capital: $866,374 as of March 31, 2026, improving from a deficit of - $181,480 as of December 31, 2025 .

#### Strategic Outlook

Blue Water Acquisition Corp. IV intends to effect a business combination with one or more businesses, specifically targeting biotechnology, healthcare, and technology companies, with the target’s fair market value being at least 80% of the net balance in the Trust Account . Following its IPO, $130,000,000 of net proceeds were placed in a trust account, invested in U.S. government treasury obligations or money market funds, to facilitate this business combination . The company’s ability to continue as a going concern is in substantial doubt, which management plans to address by issuing working capital loans and consummating an initial business combination .

### Related Stocks

- [BWIV.US](https://longbridge.com/en/quote/BWIV.US.md)

## Related News & Research

- [18:49 ETBlue Water Acquisition Corp. IV Announces Mutual Termination of Proposed Business Combination with Maha Capital](https://longbridge.com/en/news/286622372.md)
- [Maha and BWIV Terminate the Letter of Intent for Proposed SPAC Transaction](https://longbridge.com/en/news/286625069.md)
- [OceanPal Inc. Announces 2026 Annual General Meeting of Shareholders to be Held on June 16, 2026 | SVRN Stock News](https://longbridge.com/en/news/286308382.md)
- [Autohome Inc. to Announce First Quarter 2026 Financial Results on May 28, 2026 | ATHM Stock News](https://longbridge.com/en/news/286390966.md)
- [Nakamoto Reports First Quarter 2026 Results | NAKA Stock News](https://longbridge.com/en/news/286317239.md)